Difficulty: Medium
Average Score: 94%
Practice
Systemic lupus erythematosus (SLE) is often characterized by periods of smoldering disease or quiescence followed by flare and active disease. All the following lab tests correlate with active disease EXCEPT
Correct answer
A
Rationale
In systemic lupus erythematosus (SLE), periods of smoldering disease or quiescence are common, alternating with flare-ups of active disease. When the disease is active, certain lab tests reflect this increased disease activity.
Option A, the anti-nuclear antibody (ANA) titer, is not specific to active disease in SLE. ANA can be positive even during periods of quiescence. However, options B, C, and D are indicative of active disease in SLE.
Option B, anti-double-stranded DNA level, is specific to SLE and is often elevated during disease flares. Option C, low complement levels, and option D, high ESR, are also markers of inflammation and are elevated during active disease states in SLE.
Understanding these lab tests and their significance in SLE is crucial for nurses caring for pediatric patients with this condition. Recognizing the patterns of these lab results can help healthcare providers monitor disease activity, adjust treatment plans, and improve outcomes for pediatric patients with SLE.
Option A, the anti-nuclear antibody (ANA) titer, is not specific to active disease in SLE. ANA can be positive even during periods of quiescence. However, options B, C, and D are indicative of active disease in SLE.
Option B, anti-double-stranded DNA level, is specific to SLE and is often elevated during disease flares. Option C, low complement levels, and option D, high ESR, are also markers of inflammation and are elevated during active disease states in SLE.
Understanding these lab tests and their significance in SLE is crucial for nurses caring for pediatric patients with this condition. Recognizing the patterns of these lab results can help healthcare providers monitor disease activity, adjust treatment plans, and improve outcomes for pediatric patients with SLE.